Cargando…
Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186851/ https://www.ncbi.nlm.nih.gov/pubmed/34124693 http://dx.doi.org/10.1016/S2665-9913(21)00186-7 |
| _version_ | 1783705027085336576 |
|---|---|
| author | Rubbert-Roth, Andrea Vuilleumier, Nicolas Ludewig, Burkhard Schmiedeberg, Kristin Haller, Christoph von Kempis, Johannes |
| author_facet | Rubbert-Roth, Andrea Vuilleumier, Nicolas Ludewig, Burkhard Schmiedeberg, Kristin Haller, Christoph von Kempis, Johannes |
| author_sort | Rubbert-Roth, Andrea |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8186851 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81868512021-06-09 Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis Rubbert-Roth, Andrea Vuilleumier, Nicolas Ludewig, Burkhard Schmiedeberg, Kristin Haller, Christoph von Kempis, Johannes Lancet Rheumatol Comment Elsevier Ltd. 2021-07 2021-06-08 /pmc/articles/PMC8186851/ /pubmed/34124693 http://dx.doi.org/10.1016/S2665-9913(21)00186-7 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Rubbert-Roth, Andrea Vuilleumier, Nicolas Ludewig, Burkhard Schmiedeberg, Kristin Haller, Christoph von Kempis, Johannes Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis |
| title | Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis |
| title_full | Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis |
| title_fullStr | Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis |
| title_full_unstemmed | Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis |
| title_short | Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis |
| title_sort | anti-sars-cov-2 mrna vaccine in patients with rheumatoid arthritis |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186851/ https://www.ncbi.nlm.nih.gov/pubmed/34124693 http://dx.doi.org/10.1016/S2665-9913(21)00186-7 |
| work_keys_str_mv | AT rubbertrothandrea antisarscov2mrnavaccineinpatientswithrheumatoidarthritis AT vuilleumiernicolas antisarscov2mrnavaccineinpatientswithrheumatoidarthritis AT ludewigburkhard antisarscov2mrnavaccineinpatientswithrheumatoidarthritis AT schmiedebergkristin antisarscov2mrnavaccineinpatientswithrheumatoidarthritis AT hallerchristoph antisarscov2mrnavaccineinpatientswithrheumatoidarthritis AT vonkempisjohannes antisarscov2mrnavaccineinpatientswithrheumatoidarthritis |